Skip to main content
. 2013 Nov 6;66(1):16–24. doi: 10.1016/j.ihj.2013.10.001

Fig. 1.

Fig. 1

Fig. 1

a – Frequency of CYP2C19 mutant alleles in study population. b – Frequency of clopidogrel genotypes in study population. c – Frequency of CYP2C19 alleles, according to metabolizer status in the study population. d – Patient groups according to loss of function versus no loss of function genotype in the study population.